Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Della Bruna

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Antibiotics|November 1, 1983
LM 427, a new spiropiperidylrifamycin: in vitro and in vivo studiesC Della Bruna, G Schioppacassi, D Ungheri, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1989
Synthesis and antimicrobial spectrum of FCE 22101 and its orally available ester FCE 22891G Franceschi, E Perrone, M Alpegiani, et al.
The Journal of Antibiotics|October 1, 1980
Biological activity of a new class of rifamycins. Spiro-piperidyl-rifamycinsA Sanfilippo, C Della Bruna, L Marsili, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
An investigation of the pharmacokinetics and autoinduction of rifabutin metabolism in mice treated with 10 mg/kg/day six times a week for 8 weeksM Strolin Benedetti, E Pianezzola, G Brianceschi, et al.
The Journal of Antibiotics|November 1, 1983
Novel rifamycins. III. Synthesis and antibacterial activity of 3-amidino- and of 4-aminoimidazolo[4,5-c]rifamycin derivativesL Marsili, G Franceschi, M Ballabio, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1994
In-vitro and in-vivo activity of rifabutin against Toxoplasma gondiiP Olliaro, G Gorini, D Jabes, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Antibiotics|November 1, 1983
LM 427, a new spiropiperidylrifamycin: in vitro and in vivo studiesC Della Bruna, G Schioppacassi, D Ungheri, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1989
Synthesis and antimicrobial spectrum of FCE 22101 and its orally available ester FCE 22891G Franceschi, E Perrone, M Alpegiani, et al.
The Journal of Antibiotics|October 1, 1980
Biological activity of a new class of rifamycins. Spiro-piperidyl-rifamycinsA Sanfilippo, C Della Bruna, L Marsili, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
An investigation of the pharmacokinetics and autoinduction of rifabutin metabolism in mice treated with 10 mg/kg/day six times a week for 8 weeksM Strolin Benedetti, E Pianezzola, G Brianceschi, et al.
The Journal of Antibiotics|November 1, 1983
Novel rifamycins. III. Synthesis and antibacterial activity of 3-amidino- and of 4-aminoimidazolo[4,5-c]rifamycin derivativesL Marsili, G Franceschi, M Ballabio, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1994
In-vitro and in-vivo activity of rifabutin against Toxoplasma gondiiP Olliaro, G Gorini, D Jabes, et al.
Pageof 2